Survival analysis indicated varying prognostic significance of RIPK1 across multiple datasets.<h4>Conclusions</h4>miR-3921 inhibits the progression of GC, and can bind to and regulate RIPK1, indicating that both miR-3921 and RIPK1 may represent potential therapeutic targets in GC. The gene discussed is RIPK1; the disease is gastric cancer.